Effectiveness of second-generation antipsychotics with acute-phase schizophrenia
SCHIZOPHRENIA RESEARCH (2009)
期刊
SCHIZOPHRENIA RESEARCH
卷 113, 期 1, 页码 49-55出版社
ELSEVIER SCIENCE BV
关键词
类别
作者
我是这篇论文的作者
推荐
A comparative study of olanzapine, aripiprazole and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease
Liang Zhu, Guanjin Wu, Weiwei Heng, Xuefeng Zang
PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics
Dora Koller, Susana Almenara, Gina Mejia, Miriam Saiz-Rodriguez, Pablo Zubiaur, Manuel Roman, Dolores Ochoa, Marcos Navares-Gomez, Elena Santos-Molina, Elena Pintos-Sanchez, Francisco Abad-Santos
ADVANCES IN THERAPY (2021)
Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
L. A. Stabell, E. Johnsen, R. A. Kroken, E. M. Loberg, A. Blindheim, I. Joa, S. K. Reitan, M. Rettenbacher, P. Munk-Jorgensen, R. Gjestad
BMC PSYCHIATRY (2023)
Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
Valentino Racki, Marina Marcelic, Igor Stimac, Daniela Petric, Natalia Kucic
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Mechanism and kinetics of olanzapine and quetiapine oxidations at glassy carbon electrode
Raphael P. Bacil, Pedro H. M. Garcia, William Reis de Araujo, Silvia Helena Pires Serrano
ELECTROCHIMICA ACTA (2021)
Effects of the second-generation antipsychotic drugs aripiprazole and olanzapine on human adipocyte differentiation
Milica Vranic, Fozia Ahmed, Susanne Hetty, Assel Sarsenbayeva, Vitor Ferreira, Giovanni Fanni, Angela M. Valverde, Jan W. Eriksson, Maria J. Pereira
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2023)
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial
Dora Koller, Susana Almenara, Gina Mejia, Miriam Saiz-Rodriguez, Pablo Zubiaur, Manuel Roman, Dolores Ochoa, Aneta Wojnicz, Samuel Martin, Daniel Romero-Palacian, Marcos Navares-Gomez, Francisco Abad-Santos
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2021)
Pharmaco-genetic analysis of CYP1A1 and RGS4 variants and its impact on response to olanzapine and risperidone in Indian schizophrenic cohort
Rajat Garg, Sachin Kumar Saxena, Vibha Singh, Sabreen Bashir, Anuka Sharma, Varun Sharma
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH (2023)
The chemical interaction between the neurotransmitter dopamine and the antipsychotic drugs olanzapine and quetiapine
Raphael P. Bacil, Estenio A. de O. Marcondes Filho, Kevin de A. Dias, Marcelo C. Portes, William R. de Araujo, Diogo Oliveira-Silva, Alcindo A. dos Santos, Silvia H. P. Serrano
JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2021)
Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality
Jonas Berge, Paul Abri, Pontus Andell, Pouya Movahed, Dragos C. Ragazan
JOURNAL OF PSYCHIATRIC RESEARCH (2022)
Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders
Richard Houghton, Joop van den Bergh, Kiely Law, Yutong Liu, Frank de Vries
AUTISM RESEARCH (2021)
Different neurocognitive profiles of risperidone and aripiprazole in the FIRST episode of psychosis: A 3-year follow-up comparison
Esther Setien-Suero, Victor Ortiz-Garcia de la Foz, Paula Suarez-Pinilla, Benedicto Crespo-Facorro, Rosa Ayesa-Arriola
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
EFFECT OF ARIPIPRAZOLE COMBINED WITH OLANZAPINE ON THE CLINICAL EFFICACY OF SCHIZOPHRENIA
Tiancheng Jia, Xue Len, Zhilian Pi, Zhe Hong, Jin Feng, Chunhe Ma
FARMACIA (2022)
MAP Bayesian modelling combining striatal dopamine receptor occupancy and plasma concentrations to optimize antipsychotic dose regimens in individual patients
Mohamed Ismail, Thomas Straubinger, Hiroyuki Uchida, Ariel Graff-Guerrero, Shinichiro Nakajima, Takefumi Suzuki, Fernando Caravaggio, Philip Gerretsen, David Mamo, Benoit H. Mulsant, Bruce G. Pollock, Robert Bies
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Antipsychotic Drug Aripiprazole Protects Liver Cells from Oxidative Stress
Barbara Kramar, Tinkara Pirc Marolt, Maria Monsalve, Dusan Suput, Irina Milisav
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study
Ryuji Furihata, Rei Otsuki, Naomi Hasegawa, Takashi Tsuboi, Shusuke Numata, Norio Yasui-Furukori, Hiroko Kashiwagi, Hikaru Hori, Shinichiro Ochi, Hiroyuki Muraoka, Toshiaki Onitsuka, Hiroshi Komatsu, Masahiro Takeshima, Akitoyo Hishimoto, Tatsuya Nagasawa, Yoshikazu Takaesu, Toshinori Nakamura, Takeshi Asami, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Yuka Yasuda, Hitoshi Iida, Kazuyoshi Ogasawara, Naoki Hashimoto, Kayo Ichihashi, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Ryota Hashimoto
SLEEP MEDICINE (2022)
Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer's Disease
Mariko Ueno, Yuta Yoshino, Hiroaki Mori, Yu Funahashi, Hiroshi Kumon, Shinichiro Ochi, Tomoki Ozaki, Ayumi Tachibana, Taku Yoshida, Hideaki Shimizu, Takaaki Mori, Jun-ichi Iga, Shu-ichi Ueno
JOURNAL OF ALZHEIMERS DISEASE (2022)
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
Hikaru Hori, Norio Yasui-Furukori, Naomi Hasegawa, Jun-ichi Iga, Shinichiro Ochi, Kayo Ichihashi, Ryuji Furihata, Yoshitaka Kyo, Yoshikazu Takaesu, Takashi Tsuboi, Fumitoshi Kodaka, Toshiaki Onitsuka, Tsuyoshi Okada, Atsunobu Murata, Hiroko Kashiwagi, Hitoshi Iida, Naoki Hashimoto, Kazutaka Ohi, Hisashi Yamada, Kazuyoshi Ogasawara, Yuka Yasuda, Hiroyuki Muraoka, Masahide Usami, Shusuke Numata, Masahiro Takeshima, Hirotaka Yamagata, Tatsuya Nagasawa, Hiromi Tagata, Manabu Makinodan, Mikio Kido, Eiichi Katsumoto, Hiroshi Komatsu, Junya Matsumoto, Chika Kubota, Kenichiro Miura, Akitoyo Hishimoto, Koichiro Watanabe, Ken Inada, Hiroaki Kawasaki, Ryota Hashimoto
FRONTIERS IN PSYCHIATRY (2022)
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project
Kayo Ichihashi, Yoshitaka Kyou, Naomi Hasegawa, Norio Yasui-Furukori, Yoshihito Shimizu, Hikaru Hori, Naoki Hashimoto, Kenta Ide, Yayoi Imamura, Hisashi Yamada, Shinichiro Ochi, Jun-ichi Iga, Yoshikazu Takaesu, Kazutaka Ohi, Takashi Tsuboi, Hitoshi Iida, Hirotaka Yamagata, Akitoyo Hishimoto, Tadasu Horai, Masahide Usami, Manabu Makinodan, Tatsuya Nagasawa, Hiroshi Komatsu, Mikio Kido, Hiroyuki Muraoka, Kiyokazu Atake, Masahiro Takeshima, Chika Kubota, Takahiko Inagaki, Shinichiro Tamai, Taishiro Kishimoto, Ryuji Furihata, Junya Matsumoto, Kenichiro Miura, Ken Inada, Koichiro Watanabe, Kiyoto Kasai, Ryota Hashimoto
ASIAN JOURNAL OF PSYCHIATRY (2022)
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
Hisashi Yamada, Mikuni Motoyama, Naomi Hasegawa, Kenichiro Miura, Junya Matsumoto, Kazutaka Ohi, Norio Yasui-Furukori, Shusuke Numata, Masahiro Takeshima, Nobuhiro Sugiyama, Tatsuya Nagasawa, Chika Kubota, Kiyokazu Atake, Takashi Tsuboi, Kayo Ichihashi, Naoki Hashimoto, Takahiko Inagaki, Yoshikazu Takaesu, Jun-ichi Iga, Hikaru Hori, Toshiaki Onitsuka, Hiroshi Komatsu, Akitoyo Hishimoto, Kentaro Fukumoto, Michiko Fujimoto, Toshinori Nakamura, Kiyotaka Nemoto, Ryuji Furihata, Satoshi Yamamura, Hirotaka Yamagata, Kazuyoshi Ogasawara, Eiichi Katsumoto, Atsunobu Murata, Hitoshi Iida, Shinichiro Ochi, Manabu Makinodan, Mikio Kido, Taishiro Kishimoto, Yuka Yasuda, Masahide Usami, Taro Suwa, Ken Inada, Koichiro Watanabe, Ryota Hashimoto
BJPSYCH OPEN (2022)
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study
Shinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, Norio Yasui-Furukori, Jun-ichi Iga, Hiroko Kashiwagi, Fumitoshi Kodaka, Hiroshi Komatsu, Takashi Tsuboi, Akira Tokutani, Shusuke Numata, Kayo Ichihashi, Toshiaki Onitsuka, Hiroyuki Muraoka, Hitoshi Iida, Kazutaka Ohi, Kiyokazu Atake, Taishiro Kishimoto, Hikaru Hori, Yoshikazu Takaesu, Masahiro Takeshima, Masahide Usami, Manabu Makinodan, Naoki Hashimoto, Michiko Fujimoto, Ryuji Furihata, Tatsuya Nagasawa, Hisashi Yamada, Junya Matsumoto, Kenichiro Miura, Mikio Kido, Akitoyo Hishimoto, Shu-ichi Ueno, Koichiro Watanabe, Ken Inada, Ryota Hashimoto
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)
Impact of Gestational Haloperidol Exposure on miR-137-3p and Nr3c1 mRNA Expression in Hippocampus of Offspring Mice
Yuta Yoshino, Hiroshi Kumon, Tetsuya Shimokawa, Hajime Yano, Shinichiro Ochi, Yu Funahashi, Jun-ichi Iga, Seiji Matsuda, Junya Tanaka, Shu-ichi Ueno
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2022)
Secular trends in the prevalence of dementia based on a community-based complete enumeration in Japan: the Nakayama Study
Hideaki Shimizu, Takaaki Mori, Taku Yoshida, Ayumi Tachibana, Tomoki Ozaki, Yuta Yoshino, Shinichiro Ochi, Naomi Sonobe, Teruhisa Matsumoto, Kenjiro Komori, Jun-ichi Iga, Toshiharu Ninomiya, Shu-ichi Ueno, Manabu Ikeda
PSYCHOGERIATRICS (2022)
Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis
Takashi Tsuboi, Yoshikazu Takaesu, Naomi Hasegawa, Shinichiro Ochi, Kentaro Fukumoto, Kazutaka Ohi, Hiroyuki Muraoka, Tsuyoshi Okada, Funitoshi Kodaka, Shun Igarashi, Hitoshi Iida, Hiroko Kashiwagi, Hikaru Hori, Kayo Ichihashi, Kazuyoshi Ogasawara, Naoki Hashimoto, Jun-Ichi Iga, Toshinori Nakamura, Masahide Usami, Tatsuya Nagasawa, Mikio Kido, Hiroshi Komatsu, Hirotaka Yamagata, Kiyokazu Atake, Ryuji Furihata, Saya Kikuchi, Tadasu Horai, Masahiro Takeshima, Yoji Hirano, Manabu Makinodan, Junya Matsumoto, Kenichiro Miura, Akitoyo Hishimoto, Shusuke Numata, Hisashi Yamada, Norio Yasui-Furukori, Ken Inada, Koichiro Watanabe, Ryota Hashimoto
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2023)
Dissecting early life stress-induced adolescent depression through epigenomic approach
Shinichiro Ochi, Yogesh Dwivedi
MOLECULAR PSYCHIATRY (2023)
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project
Hitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, Naomi Hasegawa, Shusuke Numata, Kazuyoshi Ogasawara, Kenichiro Miura, Junya Matsumoto, Hikaru Hori, Jun-ichi Iga, Kayo Ichihashi, Naoki Hashimoto, Hisashi Yamada, Kazutaka Ohi, Norio Yasui-Furukori, Kentaro Fukumoto, Takashi Tsuboi, Masahide Usami, Ryuji Furihata, Yoshikazu Takaesu, Akitoyo Hishimoto, Hiroyuki Muraoka, Eiichi Katsumoto, Tatsuya Nagasawa, Shinichiro Ochi, Hiroshi Komatsu, Saya Kikuchi, Masahiro Takeshima, Toshiaki Onitsuka, Shinichiro Tamai, Chika Kubota, Ken Inada, Koichiro Watanabe, Hiroaki Kawasaki, Ryota Hashimoto
NEUROPSYCHOPHARMACOLOGY REPORTS (2023)
Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior
Bhaskar Roy, Shinichiro Ochi, Yogesh Dwivedi
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Prevalence of Comorbid Dementia in Late-life Depression and Bipolar Disorder: A Retrospective Inpatient Study
Shinichiro Ochi, Takaaki Mori, Jun-ichi Iga, Shu-ichi Ueno
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2022)
Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review
Shunsuke Takagi, Tatsuya Yamaguchi, Hikaru Hori, Shinichiro Ochi, Masaki Nishida, Takashi Maruo, Hidehiko Takahashi
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2022)
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
Norio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, Shinichiro Ochi, Shusuke Numata, Hikaru Hori, Akitoyo Hishimoto, Toshiaki Onitsuka, Kazutaka Ohi, Naoki Hashimoto, Tatsuya Nagasawa, Yoshikazu Takaesu, Takahiko Inagaki, Hiromi Tagata, Takashi Tsuboi, Chika Kubota, Ryuji Furihata, Jun-ichi Iga, Hitoshi Iida, Kenichiro Miura, Junya Matsumoto, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Kazutaka Shimoda, Ryota Hashimoto
NEUROPSYCHOPHARMACOLOGY REPORTS (2022)